Interactions between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer

Journal of the National Cancer Institute

Volumn 107, Issue 10, 2015, Pages

  Sundström, Karin ^a   Ploner, Alexander ^a   Arnheim Dahlström, Lisen ^a   Eloranta, Sandra ^a   Palmgren, Juni ^a,b,c   Adami, Hans Olov ^a,d   Ylitalo Helm, Nathalie ^e   Sparén, Pär ^a   Dillner, Joakim ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Linköping University   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE; VIRUS DNA;

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK HUMAN PAPILLOMAVIRUS TYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 42; LOW RISK HUMAN PAPILLOMAVIRUS TYPE; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; TUMOR INVASION; UTERINE CERVIX CANCER; VAGINA SMEAR; VIRUS LOAD; WART VIRUS; ADOLESCENT; AGED; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; REGISTER; RISK ASSESSMENT; RISK FACTOR; SWEDEN; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84944688251     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv185     Document Type: Article

References (23)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19.
2. Leval A, Herweijer E, Ploner A, et al. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst. 2013;105(7):469-474.
3. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12-F23.
4. Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. J Infect Dis. 2012;205(10):1544-1553.
5. Nordenvall C, Chang ET, Adami HO, Ye W. Cancer risk among patients with condylomata acuminata. Int J Cancer. 2006;119(4):888-893.
6. Luostarinen T, af Geijersstam V, Bjorge T, et al. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. Int J Cancer. 1999;80(6):818-822.
7. Silins I, Wang Z, Avall-Lundqvist E, et al. Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. J Gen Virol. 1999;80 (Pt 11):2931-2936.
8. Naucler P, Chen HC, Persson K, et al. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested casecontrol study. J Gen Virol. 2007;88(Pt 3):814-822.
9. Arnheim Dahlstrom L, Andersson K, Luostarinen T, et al. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(12):2541-2550.
10. Sundström K, Eloranta S, Sparen P, et al. Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2469-2478.
11. Sundström K, Ploner A, Arnheim Dahlström L, et al. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer. Cancer Epidemiol Biomarkers Prev. 2012;22(1):150-158.
12. Chua KL, Hjerpe A. Polymerase chain reaction analysis of human papillomavirus in archival cervical cytologic smears. Anal Quant Cytol Histol. 1995;17(4):221-229.
13. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995;76 (Pt 4):1057-1062.
14. Soderlund-Strand A, Rymark P, Andersson P, Dillner J, Dillner L. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J Clin Microbiol. 2005;43(7):3260-3266.
15. Soderlund-Strand A, Carlson J, Dillner J. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J Clin Microbiol. 2009;47(3):541-546.
16. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol. 2003;41(7):3221-3228.
17. R.: R core development team. 2014.
18. Hothorn T, Bretz F, Westfall P. Simultaneous Inference in General Parametric Models. Biometrica. 2008;50(3):346-363.
19. The Swedish National Quality Register for Cervical Cancer Prevention. Annual Report for 2013 with data until 2012. In Swedish. Center for Cervical Cancer Prevention. Karolinska University Hospital Huddinge, Stockholm, Sweden. 2013.
20. Dahlstrom LA, Ylitalo N, Sundstrom K, et al. Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer. 2010;127(8):1923-1930.
21. Gunnell AS, Tran TN, Torrang A, et al. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2141-2147.
22. Appleby P, Beral V, Berrington de Gonzalez A, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370(9599):1609-1621.
23. Appleby P, Beral V, Berrington de Gonzalez A, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006;118(6):1481-1495.